| Literature DB >> 34285522 |
Cong Zhou1, Qiang Wu1, Leqi He1, Hui Zhang1, Maosuo Xu1, Baoyu Yuan2, Zhi Jin3, Fang Shen1.
Abstract
BACKGROUND: The convergence of carbapenem-resistance and hypervirulence in Klebsiella pneumoniae has led to a significant public health challenge. In recent years, there have been more and more reports on carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP) isolates.Entities:
Keywords: Klebsiella pneumoniae; carbapenem-resistant; epidemiology; hypermucoviscous; hypervirulent
Year: 2021 PMID: 34285522 PMCID: PMC8286785 DOI: 10.2147/IDR.S321704
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Clinical Characteristics of 16 Patients Infected with CR-hvKP Isolates
| Isolates | Age (Years) | Sex | Ward | Underlying Conditions | Treatment | Invasive Procedures | Outcome |
|---|---|---|---|---|---|---|---|
| KP3 | 83 | F | Neurology Department | Cerebrovascular disease, type 2 diabetes mellitus, ventilator-associated pneumonia, epilepsy | SCF, TZP | Mechanical ventilation | Died |
| KP58 | 86 | F | Central ICU | Cerebrovascular disease, coronary heart disease, hypertension, urinary tract infection | TZP, TGC | Urinary catheter, Gastric tube | Survived |
| KP63 | 89 | M | Central ICU | Cerebrovascular disease, hypertension, Parkinson’s disease, renal malignancy, pulmonary infection | TGC | Mechanical ventilation | Died |
| KP104 | 74 | M | Traditional Chinese Medicine Department | Cerebrovascular disease, hypertension, urinary tract infection, pulmonary embolism | TZP, CRO | Mechanical ventilation, Urinary catheter | Survived |
| KP129 | 67 | M | Central ICU | Cerebrovascular disease, type 2 diabetes, hypertension, coronary heart disease, colon tumors | CAZ | Mechanical ventilation, Urinary catheter, Gastric tube | Died |
| KP178 | 96 | M | Geriatric Ward | Cerebrovascular disease, COPD, coronary heart disease | TZP, SCF, MER | Mechanical ventilation | Died |
| KP188 | 91 | M | Respiratory Intensive Care Unit | Chronic obstructive pulmonary disease, coronary heart disease, hypertension | TZP | Mechanical ventilation | Survived |
| KP194 | 87 | M | Central ICU | Pulmonary infection,hypertension, cerebrovascular disease | TZP, SCF, MER, CMZ | Venous catheter | Died |
| KP284 | 90 | M | Central ICU | Cerebrovascular disease,Chronic obstructive pulmonary disease | SCF | Mechanical ventilation | Died |
| KP290 | 63 | M | Central ICU | Cerebrovascular disease,hypertension,type 2 diabetes | SCF, TGC, CAZ-AVI | Mechanical ventilation, Urinary catheter | Died |
| KP298 | 83 | M | Central ICU | Cerebrovascular disease,hypertension, respiratory failure | IPM, AN | Mechanical ventilation, Urinary catheter | Died |
| KP302 | 87 | M | Gastroenterology Department | Chronic obstructive pulmonary disease,Sigmoid colon cancer | CMZ | Surgery | Survived |
| KP358 | 75 | M | General Surgery Department | Coronary heart disease, gallstone with cholecystitis, COPD | SCF, CMZ, SXT | Gastric tube | Died |
| KP359 | 85 | F | Central ICU | Cerebrovascular disease,hypertension | SCF, AN | Mechanical ventilation | Survived |
| KP374 | 102 | M | Endocrinology Department | Cerebrovascular disease, Parkinson’s disease, coronary heart disease | TZP | Urinary catheter | Survived |
| KP393 | 71 | M | Central ICU | Rectum cancer, COPD, cerebrovascular disease, hypertension | CMZ | Surgery | Survived |
Abbreviations: M, male; F, female; COPD, chronic obstructive pulmonary disease; SCF, cefoperazone/sulbactam; TZP, piperacillin/tazobactam; AN, amikacin; CMZ, cefmetazole; TGC, tigecycline; SXT, trimethoprim-sulfamethoxazole; CRO, ceftriaxone; CAZ, ceftazidime; MER, meropenem; IPM, imipenem; CAZ-AVI, ceftazidime/avibactam.
Virulence-Associated Gene Positive Rate of 39 CR-hmKP Isolates
| Virulence-Associated Gene | Viscous String Length ≤25mm (n=20) | Viscous String Length>25mm (n=19) | P value |
|---|---|---|---|
| rmpA | 6(30%) | 7(36.8%) | 0.651 |
| rmpA2 | 8(40%) | 8(42.1%) | 0.894 |
| iutA | 8(40%) | 8(42.1%) | 0.894 |
| iucA | 8(40%) | 8(42.1%) | 0.894 |
The Antimicrobial Resistance Profile of 16 CR-hvKP Isolates [n(%)]
| Antimicrobials | CR-hvKP(n=16) | |
|---|---|---|
| Susceptible | Resistant | |
| Ampicillin | 0 | 16(100) |
| Ampicillin/sulbactam | 0 | 16(100) |
| Cefoperazone/sulbactam | 0 | 16(100) |
| Piperacillin/tazobactam | 0 | 16(100) |
| Cefazolin | 0 | 16(100) |
| Cefuroxime | 0 | 16(100) |
| Ceftazidime | 0 | 16(100) |
| Ceftriaxone | 0 | 16(100) |
| Cefepime | 0 | 16(100) |
| Cefoxitin | 0 | 16(100) |
| Imipenem | 0 | 16(100) |
| Meropenem | 0 | 16(100) |
| Amikacin | 6(37.5) | 10(62.5) |
| Gentamicin | 5(31.2) | 11(68.8) |
| Ciprofloxacin | 2(12.5) | 14(87.5) |
| Trimethoprim-sulfamethoxazole | 9(56.2) | 7(43.8) |
Figure 1Virulence-associated genes, antimicrobial resistance genes, capsular serotype genes and MLST of 16 CR-hvKP isolates.
Figure 2Agarose gel electrophoresis of some virulence-associated genes, antimicrobial resistance genes and capsule serotype genes.
Figure 3ERIC-PCR DNA fingerprint of 16 CR-hvKP isolates.